...Show More Authors
Propranolol is a nonselective-adrenergic blocker used in the treatment of hypertension, cardiac arrhythmias, and
angina pectoris. A significant problem in propranolol therapy is that it undergoes extensive presystemic
metabolism after oral administration leading to reduced bioavailability. In this study, two new propranolol
derivatives have been designed, synthesized and characterized. These compounds were formed by acylation of
propranolol followed by nucleophilic substitution reaction of acylated propranolol, these derivatives were
analyzed for IR, CHN, melting points, and evaluated for their lipophilic properties compared with propranolol. The
lower partition coefficient of these two derivatives revealed that the prodrug approach may be
...
Show More